Diagnostic Role of Diffusion-Weighted and Dynamic Contrast-Enhanced Perfusion MR Imaging in Paragangliomas and Schwannomas in the Head and Neck

References

1. 1.↵
   1. Withey SJ,
   2. Perrio S,
   3. Christodoulou D, et al

   . Imaging features of succinate dehydrogenase-deficient pheochromocytoma-paraganglioma syndromes. Radiographics 2019;39:1393–1410 doi:10.1148/rg.2019180151 pmid:31498738

   CrossRefPubMed
2. 2.↵
   1. Biswas D,
   2. Marnane CN,
   3. Mal R, et al

   . Extracranial head and neck schwannomas–a 10-year review. Auris Nasus Larynx 2007;34:353–59 doi:10.1016/j.anl.2007.01.006 pmid:17376620

   CrossRefPubMed
3. 3.↵
   1. Woolen S,
   2. Gemmete JJ

   . Paragangliomas of the head and neck. Neuroimaging Clin N Am 2016;26:259–78 doi:10.1016/j.nic.2015.12.005 pmid:27154608

   CrossRefPubMed
4. 4.↵
   1. Anil G,
   2. Tan TY

   . Imaging characteristics of schwannoma of the cervical sympathetic chain: a review of 12 cases. AJNR Am J Neuroradiol 2010;31:1408–12 doi:10.3174/ajnr.A2212 pmid:20616174

   Abstract/FREE Full Text
5. 5.↵
   1. Ota Y,
   2. Naganawa S,
   3. Kurokawa R, et al

   . Assessment of MR imaging and CT in differentiating hereditary and nonhereditary paragangliomas. AJNR Am J Neuroradiol 2021;42:1320–26 doi:10.3174/ajnr.A7166 pmid:33985956

   Abstract/FREE Full Text
6. 6.↵
   1. Williams MD

   . Paragangliomas of the head and neck: an overview from diagnosis to genetics. Head Neck Pathol 2017;11:278–87 doi:10.1007/s12105-017-0803-4 pmid:28321772

   CrossRefPubMed
7. 7.↵
   1. Behuria S,
   2. Rout TK,
   3. Pattanayak S

   . Diagnosis and management of schwannomas originating from the cervical vagus nerve. Ann R Coll Surg Engl 2015;97:92–97 doi:10.1308/003588414X14055925058355 pmid:25723683

   CrossRefPubMed
8. 8.↵
   1. Griffith B,
   2. Jain R

   . Perfusion imaging in neuro-oncology: basic techniques and clinical applications. Radiol Clin North Am 2015;53:497–511 doi:10.1016/j.rcl.2015.01.004 pmid:25953286

   CrossRefPubMed
9. 9.↵
   1. Cuenod CA,
   2. Balvay D

   . Perfusion and vascular permeability: basic concepts and measurement in DCE-CT and DCE-MRI. Diagn Interv Imaging 2013;94:1187–1204 doi:10.1016/j.diii.2013.10.010 pmid:24211260

   CrossRefPubMed
10. 10.↵
    1. Gaddikeri S,
    2. Hippe DS,
    3. Anzai Y

    . Dynamic contrast-enhanced MRI in the evaluation of carotid space paraganglioma versus schwannoma. J Neuroimaging 2016;26:618–25 doi:10.1111/jon.12351 pmid:27102237

    CrossRefPubMed
11. 11.↵
    1. Yuan Y,
    2. Shi H,
    3. Tao X

    . Head and neck paragangliomas: diffusion weighted and dynamic contrast enhanced magnetic resonance imaging characteristics. BMC Med Imaging 2016;16:12 doi:10.1186/s12880-016-0114-3 pmid:26833065

    CrossRefPubMed
12. 12.↵
    1. Gaddikeri S,
    2. Gaddikeri RS,
    3. Tailor T, et al

    . Dynamic contrast-enhanced MR imaging in head and neck cancer: techniques and clinical applications. AJNR Am J Neuroradiol 2016;37:588–95 doi:10.3174/ajnr.A4458 pmid:26427839

    Abstract/FREE Full Text
13. 13.↵
    1. Ota Y,
    2. Liao E,
    3. Kurokawa R, et al

    . Diffusion-weighted and dynamic contrast-enhanced MRI to assess radiation therapy response for head and neck paragangliomas. J Neuroimaging 2021 May 8. [Epub ahead of print] doi:10.1111/jon.12875 pmid:34002429

    CrossRefPubMed
14. 14.↵
    1. Srinivasan A,
    2. Dvorak R,
    3. Perni K, et al

    . Differentiation of benign and malignant pathology in the head and neck using 3T apparent diffusion coefficient values: early experience. AJNR Am J Neuroradiol 2008;29:40–44 doi:10.3174/ajnr.A0743 pmid:17921228

    CrossRefPubMed
15. 15.↵
    1. Koontz NA,
    2. Wiggins RH 3rd..

    Differentiation of benign and malignant head and neck lesions with diffusion tensor imaging and DWI. AJR Am J Roentgenol 2017;208:1110–15 doi:10.2214/AJR.16.16486 pmid:28245145

    CrossRefPubMed
16. 16.↵
    1. Landis JR,
    2. Koch GG

    . The measurement of observer agreement for categorical data. Biometrics 1977;33:159 doi:10.2307/2529310 pmid:843571

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Offergeld C,
    2. Brase C,
    3. Yaremchuk S, et al

    . Head and neck paragangliomas: clinical and molecular genetic classification. Clinics (Sao Paulo) 2012;67:19–28 doi:10.6061/clinics/2012(Sup01)05 pmid:22249476

    CrossRefPubMed
18. 18.↵
    1. Papiez J,
    2. Rojiani MV,
    3. Rojiani AM

    . Vascular alterations in schwannoma. Int J Clin Exp Pathol 2014;7:4032–38 pmid:25120781

    PubMed
19. 19.↵
    1. Sourbron SP,
    2. Buckley DL

    . On the scope and interpretation of the Tofts models for DCE-MRI. Magn Reson Med 2011;66:735–45 doi:10.1002/mrm.22861 pmid:21384424

    CrossRefPubMed
20. 20.↵
    1. Zhao M,
    2. Guo LL,
    3. Huang N, et al

    . Quantitative analysis of permeability for glioma grading using dynamic contrast-enhanced magnetic resonance imaging. Oncol Lett 2017;14:5418–26 doi:10.3892/ol.2017.6895 pmid:29113174

    CrossRefPubMed
21. 21.↵
    1. Tischler AS,
    2. deKrijger RR

    . 15 years of paraganglioma: pathology of pheochromocytoma and paraganglioma. Endocr Relat Cancer 2015;22:T123–33 doi:10.1530/ERC-15-0261 pmid:26136457

    Abstract/FREE Full Text